|
End-of-day quote
Mexican S.E.
10/09/2026
|
5-day change | 1st Jan Change | ||
| 2,453.18 MXN | -1.08% |
|
0.00% | +10.39% |
| 09-18 | Dr. Reddy's Confirms License for Gilead's Yearly-Once HIV Drug; Shares Up 2% | MT |
| 09-16 | Gilead Sciences Insider Sold Shares Worth $432,646, According to a Recent SEC Filing | MT |
Stock exchange
Mexican S.E.
GILD * 2,453.18 $
-1.08%
1.62M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GILD | 150.11USD | -0.52% | 2.47B $ | ||
CBOE
| GILD | 150.04USD | -0.62% | 31.83M $ | |
|
Tradegate
| GIS | 130.62EUR | -0.62% | 292K € | |
|
Mexican S.E.
| GILD * | 2,453.18MXN | -1.08% | 1.62M $ | |
|
Xetra
| GIS | 131.20EUR | +1.03% | 29.52K € | |
|
Boerse Muenchen
| GIS | 130.70EUR | -0.53% | 9.8K € | |
|
Deutsche Boerse AG
| GIS | 131.64EUR | +1.26% | 8.16K € | |
|
Börse Stuttgart
| GIS | 131.34EUR | +0.52% | 3.68K € | |
|
Borsa Italiana
| 1GILD | 131.04EUR | +1.24% | 3.41K € | |
|
Wiener Boerse
| GILD | 130.98EUR | +1.17% | 1.05K € | |
|
London S.E.
| 0QYQ | 151.50USD | +2.02% | 151.5 $ | |
|
Santiago S.E.
| GILD | 146.41USD | 0.00% | 0 $ | |
|
Swiss Exchange
| GILD | 149.34USD | +1.22% | 0 $ | |
|
Lima
| GILDUS | 146.41USD | 0.00% | 0 $ | |
|
Santiago S.E.
| GILDCL | 140,190.00CLP | 0.00% | 0 $ | |
|
Swiss Exchange
| GILD | 122.98CHF | +1.10% | 0 CHF | |
|
CBOE
| 0QYQ | 124.74EUR | 0.00% | 0 € | |
|
CBOE
| 128.63EUR | 0.00% | 0 € | ||
| GILD34 | 64.80BRL | +0.25% | 1.49K R$ | ||
| GILD | 60,100.00ARS | +0.12% | 108M $ | ||
|
Buenos Aires S.E.
| GILDD | 39.33USD | +4.21% | 825.93 $ | |
| GILD | 30.25CAD | -0.30% | 719K $ | ||
|
Deutsche Boerse AG
| GIS0 | 18.70EUR | +1.63% | 0 € |
Quotes 5-day view: Gilead Sciences, Inc.
End-of-day quote Mexican S.E.| 10/09/2026 | |
|---|---|
| Last | MX$2,453.18 |
| Volume | 660 |
| Change | - |
| Opening | MX$2,453.18 |
| High | MX$2,453.18 |
| Low | MX$2,453.18 |
Performance
| 1 day | -1.08% | ||
| Current month | -0.68% | ||
| 1 month | +2.72% | ||
| 3 months | +15.87% | ||
| 6 months | -1.83% | ||
| Current year | +10.39% | ||
| 1 year | +19.49% | ||
| 3 years | +90.17% | ||
| 5 years | +73.00% | ||
| 10 years | +60.56% |
Volumes
marketsDaily volume
660
Avg. Volume 20 sessions
4,140
Avg. Volume 20 sessions MXN
10,156,165.2
Avg. Volume 20 sessions USD
589,819.29
Record volume 1
232,454
Record volume 2
203,163
Record volume 3
199,733
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (MXN)
186,129,668,317
Market Cap (USD)
186,129,668,317
Net sales (USD)
29,443,000,000
Number of employees
17,000
Sales / Employee (USD)
1,731,941
Free-Float
99.88%
Free-Float capitalization (MXN)
10,768,840,176
Free-Float capitalization (USD)
185,907,872,386
Average Daily Capital Traded
0.01%
Indicators
Moving average 5 days
2,497.25
Moving average 20 days
2,395.54
Moving average 50 days
2,358.6
Moving average 100 days
2,293.57
Price spread / (MMA5)
+1.80%
Price spread / (MMA20)
-2.35%
Price spread / (MMA50)
-3.86%
Price spread / (MMA100)
-6.51%
RSI 9 days
53.38
RSI 14 days
55.13
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.08% | 0.00% | +19.49% | +90.17% | 186B | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| Average | -0.08% | +3.26% | +24.67% | +49.83% | 378.79B | |
| Weighted average by Cap. | -0.09% | +3.09% | +34.09% | +63.01% |
Historical Quotes: Gilead Sciences, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 month | 2,453.18 |  | 2,553.46 |
| Current year | 2,116 | | 2,618.71 |
| 1 year | 2,025.32 | | 2,618.71 |
| 3 years | 1,046.71 | | 2,618.71 |
| 5 years | 1,046.71 | | 2,618.71 |
| 10 years | 1,046.71 | | 2,618.71 |
Monthly variations
Annual variations
| 2026 | +10.39% | ||
| 2025 | +18.84% | ||
| 2024 | +36.70% | ||
| 2023 | -16.23% | ||
| 2022 | +8.04% | ||
| 2021 | +32.82% | ||
| 2020 | -8.23% | ||
| 2019 | +0.80% | ||
| 2018 | -14.10% | ||
| 2017 | -3.24% | ||
| 2016 | -15.58% | ||
| 2015 | +24.34% | ||
| 2014 | +43.73% | ||
| 2013 | +106.91% | ||
| 2012 | +81.45% | ||
| 2011 | +12.56% | ||
| 2010 | -16.72% | ||
| 2009 | -5.56% | ||
| 2008 | +4.76% |
- Stock Market
- Stocks
- GILD Stock
- GILD * Stock
- Quotes Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
